Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women

by L.G. Bekker, S. Li, S. Pathak, E.E. Tolley, M.A. Marzinke, J.E. Justman, N.M. Mgodi, M. Chirenje, S. Swaminathan, A. Adeyeye, J. Farrior, C.W. Hendrix, E. Piwowar-Manning, P. Richardson, S.H. Eshelman, H. Redinger, P. Williams, N.D. Sista
Published 2020-04-01